Biogen has applied for the endorsement of its Alzheimer’s medication, Aduhelm, to the Korean regulator
Biogen’s Alzheimer’s medication Aduhelm (Ingredient: Aducanumab), which has as of late got endorsement from the U.S. Food and Drug Administration,
Read more